ANI Pharmaceuticals, Inc.
DE ˙ DB ˙ US00182C1036
54,50 € 0,00 (0,00%)
2023-08-21
AKTIENPREIS
SecurityDE:BSFA / ANI Pharmaceuticals, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership497,702 shares
Latest Disclosed Value $ 38,273,284
UBS Group AG reports 230.09% increase in ownership of BSFA / ANI Pharmaceuticals, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 497,702 shares of ANI Pharmaceuticals, Inc. (DE:BSFA) valued at $38,273,284 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 150,779 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of 230.09% during the quarter. The current value of the position is $27,124,759 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F ANI PHARMACEUTICALS COM 00182C103 497,702 346,923 230.09 38,273 221.57 0.0011
2026-01-29 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 150,779 -439,095 -74.44 11,902 -77.97 0.0019
2025-11-13 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 589,874 185,172 45.76 54,032 104.62 0.0085
2025-08-14 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 404,702 140,312 53.07 26,407 49.19 0.0046
2025-05-13 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 264,390 -330,420 -55.55 17,701 -46.17 0.0033
2025-02-14 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 594,810 308,322 107.62 32,881 92.39 0.0061
2024-11-14 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 286,488 254,514 796.00 17,092 739.44 0.0037
2024-08-14 2024-06-30 13F ANI PHARMACEUTICALS COM 00182C103 31,974 14,512 83.11 2,036 68.68 0.0005
2024-05-13 2024-03-31 13F ANI PHARMACEUTICALS COM 00182C103 17,462 -1,569 -8.24 1,207 15.06 0.0003
2024-02-09 2023-12-31 13F ANI PHARMACEUTICALS COM 00182C103 19,031 12,853 208.04 1,049 193.02 0.0003
2023-11-09 2023-09-30 13F ANI PHARMACEUTICALS COM 00182C103 6,178 -25,895 -80.74 359 -79.26 0.0001
2023-08-11 2023-06-30 13F ANI PHARMACEUTICALS COM 00182C103 32,073 20,376 174.20 1,726 271.98 0.0006
2023-05-12 2023-03-31 13F ANI PHARMACEUTICALS COM 00182C103 11,697 4,880 71.59 465 69.34 0.0002
2023-02-08 2022-12-31 13F ANI PHARMACEUTICALS COM 00182C103 6,817 6,773 15,393.18 274 27,300.00 0.0001
2022-11-10 2022-09-30 13F ANI PHARMACEUTICALS COM 00182C103 44 44 1 0.0000
2022-08-10 2022-06-30 13F ANI PHARMACEUTICALS COM 00182C103 0 -481 -100.00 0 -100.00
2022-05-16 2022-03-31 13F ANI PHARMACEUTICALS COM 00182C103 481 -5,420 -91.85 14 -94.87 0.0000
2022-02-14 2021-12-31 13F ANI PHARMACEUTICALS COM 00182C103 5,901 4,274 262.69 273 415.09 0.0001
2021-11-15 2021-09-30 13F ANI PHARMACEUTICALS COM 00182C103 1,627 -733 -31.06 53 -36.14 0.0000
2021-08-13 2021-06-30 13F ANI PHARMACEUTICALS COM 00182C103 2,360 -1,603 -40.45 83 -42.36 0.0000
2021-05-12 2021-03-31 13F ANI PHARMACEUTICALS COM 00182C103 3,963 -1,030 -20.63 144 -0.69 0.0000
2021-02-11 2020-12-31 13F ANI PHARMACEUTICALS COM 00182C103 4,993 -2,988 -37.44 145 -35.84 0.0000
2020-11-12 2020-09-30 13F ANI PHARMACEUTICALS COM 00182C103 7,981 -10,009 -55.64 226 -61.10 0.0001
2020-07-31 2020-06-30 13F ANI PHARMACEUTICALS COM 00182C103 17,990 10,373 136.18 581 86.82 0.0002
2020-05-01 2020-03-31 13F ANI PHARMACEUTICALS COM 00182C103 7,617 -7,578 -49.87 311 -66.81 0.0001
2020-02-14 2019-12-31 13F ANI PHARMACEUTICALS COM 00182C103 15,195 5,521 57.07 937 32.72 0.0003
2019-11-14 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 9,674 5,384 125.50 706 100.00 0.0003
2019-08-14 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 4,290 4,170 3,475.00 353 4,312.50 0.0001
2019-05-14 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 120 -98 -44.95 8 -20.00 0.0000
2019-02-14 2018-12-31 13F ANI PHARMACEUTICALS COM 00182C103 218 -1,536 -87.57 10 -89.90 0.0000
2018-11-14 2018-09-30 13F ANI PHARMACEUTICALS COM 00182C103 1,754 1,085 162.18 99 120.00 0.0000
2018-08-14 2018-06-30 13F ANI PHARMACEUTICALS COM 00182C103 669 -835 -55.52 45 -48.86 0.0000
2018-05-15 2018-03-31 13F ANI PHARMACEUTICALS COM 00182C103 1,504 1,208 408.11 88 363.16 0.0000
2018-02-14 2017-12-31 13F ANI PHARMACEUTICALS COM 00182C103 296 -2,496 -89.40 19 -87.07 0.0000
2017-11-14 2017-09-30 13F ANI PHARMACEUTICALS COM 00182C103 2,792 558 24.98 147 40.00 0.0001
2017-11-14 2017-06-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 2,234 -2,378 -51.56 105 -53.95 0.0001
2017-08-14 2017-06-30 13F ANI PHARMACEUTICALS COM 00182C103 2,234 -2,378 105
2017-11-14 2017-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 4,612 -2,287 -33.15 228 -45.45 0.0001
2017-05-12 2017-03-31 13F ANI PHARMACEUTICALS COM 00182C103 4,612 -2,287 228
2017-02-14 2016-12-31 13F ANI PHARMACEUTICALS COM 00182C103 6,899 -12,388 -64.23 418 -67.34 0.0002
2016-11-14 2016-09-30 13F ANI PHARMACEUTICALS COM 00182C103 19,287 4,748 32.66 1,280 57.64 0.0008
2016-08-12 2016-06-30 13F ANI PHARMACEUTICALS COM 00182C103 14,539 12,613 654.88 812 1,149.23 0.0005
2016-05-12 2016-03-31 13F ANI PHARMACEUTICALS COM 00182C103 1,926 -29 -1.48 65 -26.14 0.0000
2016-02-16 2015-12-31 13F ANI PHARMACEUTICALS COM 00182C103 1,955 1,896 3,213.56 88 4,300.00 0.0001
2015-11-13 2015-09-30 13F ANI PHARMACEUTICALS COM 00182C103 59 -8,590 -99.32 2 -99.63 0.0000
2015-08-14 2015-06-30 13F ANI PHARMACEUTICALS COM 00182C103 8,649 5,930 218.09 537 215.88 0.0004
2015-05-14 2015-03-31 13F ANI PHARMACEUTICALS COM 00182C103 2,719 1,969 262.53 170 304.76 0.0001
2015-02-17 2014-12-31 13F ANI PHARMACEUTICALS COM 00182C103 750 750 42 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.